Early therapeutic response as a prognostic indicator in autologous HSCT for multiple sclerosis

Key Points

• Early therapeutic response significantly predicts long-term outcomes in multiple sclerosis, enhancing treatment decisions.
• Clinicians observed a marked improvement in prognosis based on early biomarkers, potentially altering patient management.
• Assessment of therapeutic response introduced a new approach for evaluating treatment effectiveness in multiple sclerosis cases.
• Findings suggest that focusing on early responses could reshape treatment strategies, enhancing patient quality of life.